Shenzhen Kangtai Biological Products Co.,Ltd.

The company was founded in 1992, focusing on R&D, production and sales of human vaccines. It has now become one of the leading innovative biopharmaceutical enterprises with strong domestic R&D strength, rich product layout, leading industrial scale, and remarkable progress in internationalization. The company's main business is research and development, production and sales of human vaccines. Major products include recombinant hepatitis B vaccine (10ug, 20ug, 60ug), 23-valent pneumococcal polysaccharide vaccine, acellular haemophilus influenzae type b combination vaccine, 13-valent pneumococcal conjugate vaccine, and freeze-dried human rabies vaccine (human diploid cells). The company has received honors such as Guangdong Innovative Enterprise, Guangdong High-tech Product Certificate, National Torch Program Key High-tech Enterprise Certificate, Guangdong Youth Leading Enterprise, and Shenzhen Science and Technology Progress Award.